Full-Time

Director – Target Profiling

Translational Research

Posted on 12/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Expected to be in office 70% of the time with flexibility to work from home up to 30%.

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Ph.D. in a relevant scientific discipline (e.g., oncology, immunology, cancer biology, immune-oncology) with a minimum of 10 years of experience in translational research within the pharmaceutical or biotechnology industry, preferably in immune-oncology or autoimmune therapeutic areas.
  • Proven expertise in developing and validating CDx assays and disease monitoring tools.
  • Strong background in developing flow cytometry, ctDNA sequencing, MRD methodologies, and protein-based assays to inform clinical development.
  • Excellent communication and collaboration skills, with experience working in cross-functional teams.
  • A results-driven mindset, capable of thriving in a fast-paced, innovative environment.
  • A passion for advancing precision medicine to improve outcomes for patients.
  • Demonstrated ability to innovate translational approaches for novel therapeutic concepts or modalities.
  • Experience with regulatory submissions and interactions with health authorities is highly desirable.
  • Demonstrated success in developing and integrating companion diagnostics into therapeutic development strategies.
  • Excellent project management and organizational skills, with the ability to manage multiple cancer vaccine projects simultaneously.
  • Strong leadership and interpersonal skills, with the ability to influence and lead cross-functional teams.
  • Demonstrated proficiency in effectively managing and developing direct reports.
  • Exceptional communication skills, both written and verbal, with the ability to effectively convey complex scientific information related to cancer vaccines to a variety of audiences.
  • A strong publication record in peer-reviewed journals is preferred, particularly in the field of cancer immunotherapy or autoimmunity.
Responsibilities
  • Develop and validate cutting-edge methodologies, including ctDNA, MRD, and protein-based assays, to monitor disease progression and therapeutic efficacy in a variety of clinical settings and disease indications.
  • Lead the development of stage-appropriate CDx assays to enable precision patient profiling and inform strategies for therapeutic intervention.
  • Manage the implementation of flow cytometry and other advanced profiling techniques to characterize and/or stratify patient populations effectively.
  • Collaborate with Preclinical Program teams, Translational Medicine and Clinical Biomarker teams to define and implement comprehensive translational strategies to drive programs from concept to clinic.
  • Stay at the forefront of scientific and technological advancements in precision targeting and companion diagnostics.
  • Contribute to the broader translational research team strategy, fostering innovation and excellence.
  • Oversee relationships with CROs and internal labs to ensure the timely completion of assay development, qualification, and validation studies, delivering high-quality data for translational research projects.
  • Mentor and develop junior scientists within the translational research team, fostering a culture of scientific excellence and continuous learning.
  • Act as a scientific liaison and thought partner for key internal and external collaborators, including development and regulatory colleagues, academic institutions, and industry collaborators in the oncology space.
  • Contribute to the preparation of regulatory submissions, scientific publications, and presentations, effectively communicating translational research outcomes.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more direct and efficient way to instruct cells to produce therapeutic proteins. The company's goal is to improve patient outcomes by harnessing the power of mRNA technology to create effective treatments for a range of diseases.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

3%

1 year growth

15%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's new plant in Shanghai expands its manufacturing and market presence in Asia.
  • The Victoria vaccine facility enhances Moderna's global production capacity.
  • Collaboration with OpenAI may enhance drug discovery and development processes.

What critics are saying

  • Legal challenges over mRNA technology could impact financial stability.
  • Hong Kong residents' vaccine reticence may affect market penetration.
  • Internal restructuring may affect strategic decision-making and company culture.

What makes Moderna unique

  • Moderna is pioneering mRNA as a new class of medicines.
  • The company has developed one of the earliest effective COVID-19 vaccines.
  • Moderna's mRNA platform targets infectious, rare, and autoimmune diseases.

Help us improve and share your feedback! Did you find this helpful?